Your browser doesn't support javascript.
loading
Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatis.
Visan, Lucian; Sanchez, Violette; Kania, Margaux; de Montfort, Aymeric; de la Maza, Luis M; Ausar, Salvador Fernando.
Affiliation
  • Visan L; a Research & Non Clinical Safety Department , Sanofi Pasteur , Marcy l'Etoile , France.
  • Sanchez V; a Research & Non Clinical Safety Department , Sanofi Pasteur , Marcy l'Etoile , France.
  • Kania M; b Bioprocess Research and Development, Sanofi Pasteur , Toronto , ON , Canada.
  • de Montfort A; a Research & Non Clinical Safety Department , Sanofi Pasteur , Marcy l'Etoile , France.
  • de la Maza LM; c Department of Pathology and Laboratory Medicine , Medical Sciences I, University of California , Irvine , CA , USA.
  • Ausar SF; b Bioprocess Research and Development, Sanofi Pasteur , Toronto , ON , Canada.
Hum Vaccin Immunother ; 12(9): 2341-50, 2016 09.
Article in En | MEDLINE | ID: mdl-27104338
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Phosphates / Bacterial Outer Membrane Proteins / Bacterial Vaccines / Chlamydia trachomatis / Adjuvants, Immunologic / Toll-Like Receptor 4 / Aluminum Hydroxide / Aluminum Oxide Language: En Journal: Hum Vaccin Immunother Year: 2016 Type: Article Affiliation country: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Phosphates / Bacterial Outer Membrane Proteins / Bacterial Vaccines / Chlamydia trachomatis / Adjuvants, Immunologic / Toll-Like Receptor 4 / Aluminum Hydroxide / Aluminum Oxide Language: En Journal: Hum Vaccin Immunother Year: 2016 Type: Article Affiliation country: France